Feasibility of Redo-Transcatheter Aortic Valve Replacement in Sapien Valves Based on In Vivo Computed Tomography Assessment.
Miho FukuiAtsushi OkadaKiahltone R ThaoMarcus R BurnsHideki KoikeCheng WangAsa PhichaphopJohn R LesserPaul SorajjaJoão L CavalcanteVinayak N BapatPublished in: Circulation. Cardiovascular interventions (2023)
Redo-TAV replacement with S3-in-S3 and Evolut-in-S3 could be feasible with low risk to coronaries in ≈60% of patients, while the remaining 40% will be at intermediate or high risk. The feasibility of redo-TAV replacement is influenced by sizing strategy, type of second TAV, native annular anatomy, and implant depth.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve replacement
- aortic stenosis
- aortic valve
- transcatheter aortic valve implantation
- ejection fraction
- computed tomography
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- peritoneal dialysis
- positron emission tomography
- left ventricular
- optical coherence tomography
- contrast enhanced